Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9378 | 1092 | 28.4 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1864 | 5519 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAS 15687 21 1 | Author keyword | 1 | 100% | 0% | 2 |
2 | 15 HYDROXY EICOSATETRAENOIC ACID | Author keyword | 1 | 50% | 0% | 1 |
3 | 15 OH PROSTAGLANDIN DEHYDROGENASE | Author keyword | 1 | 50% | 0% | 1 |
4 | BY ACTIVATED MACROPHAGES | Author keyword | 1 | 50% | 0% | 1 |
5 | DIAGNOSTIC SCREENING METHOD | Author keyword | 1 | 50% | 0% | 1 |
6 | FUNDAMENTAL EXPT PHARMACOSCI | Address | 1 | 50% | 0% | 1 |
7 | HONGOBUNKYO KU | Address | 1 | 50% | 0% | 1 |
8 | IMPLANTED IN NUDE MICE | Author keyword | 1 | 50% | 0% | 1 |
9 | MED MED SURG TRANSPLANTAT | Address | 1 | 50% | 0% | 1 |
10 | THROMBOXANE B 2TXB2 | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2ND MESSENGER ROLE | 4 | 75% | 0% | 3 |
2 | HUMAN CYCLOSPORINE NEPHROTOXICITY | 4 | 75% | 0% | 3 |
3 | REGULATE INTERLEUKIN 1 PRODUCTION | 2 | 67% | 0% | 2 |
4 | 15 HYDROXYDEHYDROGENASE | 1 | 50% | 0% | 1 |
5 | ENHANCED INTERLEUKIN 1 | 1 | 50% | 0% | 1 |
6 | MOUSE THYMIC RETICULUM | 1 | 50% | 0% | 1 |
7 | PROSTAGLANDIN E1 ANALOG | 1 | 13% | 0% | 4 |
8 | THROMBOXANE SYNTHASE INHIBITION | 0 | 13% | 0% | 3 |
9 | EXERCISE TRAINING REGIMEN | 0 | 33% | 0% | 1 |
10 | NEOPLASTIC CELLS INVITRO | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ROLE OF THYMUS-EICOSANOIDS IN THE IMMUNE-RESPONSE | 1992 | 27 | 78 | 44% |
INVOLVEMENT OF INFLAMMATORY MEDIATORS IN MACROPHAGE ANTITUMOR-ACTIVITY | 1993 | 117 | 152 | 20% |
REGULATION OF THE IMMUNE-RESPONSE BY PROSTAGLANDINS | 1983 | 725 | 102 | 42% |
LYMPHOCYTES AND ARACHIDONIC-ACID METABOLISM | 1988 | 40 | 26 | 88% |
INTERACTIONS BETWEEN INFLAMMATORY MEDIATORS IN EXPRESSION OF ANTITUMOR CYTOSTATIC ACTIVITY OF MACROPHAGES | 1990 | 13 | 23 | 65% |
LEUKOTRIENES AND THE IMMUNE-SYSTEM | 1989 | 23 | 61 | 54% |
IMMUNOREGULATION BY LEUKOTRIENES AND OTHER LIPOXYGENASE METABOLITES | 1985 | 157 | 68 | 35% |
THE 5-LIPOXYGENASE PATHWAY IN NORMAL AND MALIGNANT HUMAN B-LYMPHOCYTES | 1995 | 3 | 23 | 52% |
PROSTAGLANDINS AS PHYSIOLOGICAL IMMUNOREGULATORS | 1988 | 39 | 18 | 44% |
MONONUCLEAR PHAGOCYTES AND EICOSANOIDS - ASPECTS OF THEIR SYNTHESIS AND BIOLOGICAL-ACTIVITIES | 1989 | 20 | 93 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUNDAMENTAL EXPT PHARMACOSCI | 1 | 50% | 0.1% | 1 |
2 | HONGOBUNKYO KU | 1 | 50% | 0.1% | 1 |
3 | MED MED SURG TRANSPLANTAT | 1 | 50% | 0.1% | 1 |
4 | PHARMACEUT SCI CHEM TOXICOL IMMUNOCHEM | 0 | 20% | 0.1% | 1 |
5 | BIOL CELLULAR MOL PATHOL L CALIFANO | 0 | 17% | 0.1% | 1 |
6 | KLIN POLIKLIN INNERE MED NEPHROL 2 | 0 | 11% | 0.1% | 1 |
7 | INT PHARM HLTH SCI | 0 | 100% | 0.1% | 1 |
8 | INVEST UNIDAD IMMUNOL EXPTL | 0 | 100% | 0.1% | 1 |
9 | MED VIRGINIA CARDIAC SURG | 0 | 100% | 0.1% | 1 |
10 | P ALLERGY IMMUNOL INFECT DIS | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000137206 | 5 OXO ETE//CLAUDE PEPPER//5 HETE |
2 | 0.0000118914 | WARD COLON TUMOR//MAIF//MAMMARY TUMOR BEARERS |
3 | 0.0000102549 | WHOLE BLOOD CELL CULTURES//COLORIMETRY METHOD//HUMAN COLORECTAL TUMORS |
4 | 0.0000101227 | SIMULTANEOUS INFUSION//PYROGENAL//VACCINE TECHNOL UNIT |
5 | 0.0000079120 | 15S 15 METHYLPROSTAGLANDIN F 2 ALPHA METHYL ESTER//NON SYNCHRONOUS SHIFT//PARTIAL EXTRACT WITHDRAWAL |
6 | 0.0000076610 | OMEGA 3 LIPIDS//ENVIRONM RURAL HLTH//PROGRAM INTEGRAT NUTR COMPLEX DIS |
7 | 0.0000072702 | MTP PE//LIPOSOMAL MTP PE//L MTP PE |
8 | 0.0000069175 | HEPATIC OXYGEN DELIVERY//OP 2507//PGE1 |
9 | 0.0000067074 | 5 LIPOXYGENASE//LEUKOTRIENE A4 HYDROLASE//5 LIPOXYGENASE ACTIVATING PROTEIN |
10 | 0.0000066333 | DGLA//DIHOMO GAMMA LINOLENIC ACID//EVENING PRIMROSE OIL |